Biocon Q2 FY27 consolidated revenue Rs 4,388.90 cr, PAT Rs 56.70 cr
Biocon’s consolidated Q2 FY27 revenue from operations was Rs 4,388.90 cr and profit after tax Rs 56.70 cr, versus Rs 4,295.50 cr and Rs 132.80 cr a year earlier.
Key takeaways
- Revenue from operations Rs 4,388.90 cr vs Rs 4,295.50 cr a year earlier
- Total income Rs 4,423.40 cr compared with Rs 4,388.50 cr in Q2 FY26
- Total expenses Rs 4,361.90 cr vs Rs 4,205.30 cr in the corresponding quarter
- Profit for the period Rs 56.70 cr vs Rs 132.80 cr a year earlier
- Basic EPS 0.25 vs 0.66 for the quarter ended 30.09.2025
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 4,388.90 cr | Rs 4,295.50 cr | +2.2% |
| PAT | Rs 56.70 cr | Rs 132.80 cr | -57.3% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 1.29% of revenue, down 179 bps from 3.09%.
- Total expenses rose 3.7% while revenue rose 2.2%.
- Cost of materials took 38.0% of revenue, against 31.8% a year earlier.
• Basis: Consolidated statement of unaudited financial results for the 3 months ended 30.09.2026, with comparison to 3 months ended 30.09.2025.
Key P&L figures (consolidated, Rs in Million unless stated otherwise):
- Revenue from operations: Rs 43,889 (Q2 FY26: Rs 42,955)
- Other income: Rs 345 (Q2 FY26: Rs 930)
- Total income: Rs 44,234 (Q2 FY26: Rs 43,885)
- Cost of materials consumed: Rs 16,690 (Q2 FY26: Rs 13,675)
- Purchases of stock-in-trade: Rs 3,112 (Q2 FY26: Rs 1,350)
- Changes in inventories of finished goods, work-in-progress and stock-in-trade: Rs (4,588) (Q2 FY26: Rs 445)
- Employee benefits expense: Rs 8,919 (Q2 FY26: Rs 8,982)
- Finance costs: Rs 2,401 (Q2 FY26: Rs 2,722)
- Depreciation and amortisation expense: Rs 5,638 (Q2 FY26: Rs 4,730)
- Other expenses: Rs 11,892 (Q2 FY26: Rs 10,281)
- Total expenses: Rs 43,619 (Q2 FY26: Rs 42,053)
- Profit before share of profit of joint venture and associate, exceptional items and tax (3-2): Rs 615 (Q2 FY26: Rs 1,832)
- Profit before exceptional items and tax (5): Rs 615 (Q2 FY26: Rs 1,832)
- Exceptional items (net): Rs (67) (Q2 FY26: Rs (119))
- Profit before tax (7): Rs 548 (Q2 FY26: Rs 1,713)
- Current tax charge: Rs 308 (Q2 FY26: Rs 593)
- Deferred tax charge: Rs (327) (Q2 FY26: Rs (208))
- Profit for the period/year (9): Rs 567 (Q2 FY26: Rs 1,328)
- Paid-up equity share capital (Face value of Rs. 5 each): Rs 8,148 (Q2 FY26: Rs 6,685)
- Earnings per share (Face value of Rs. 5 each, not annualised):
- Basic: 0.25 (Q2 FY26: 0.66)
- Diluted: 0.25 (Q2 FY26: 0.65)
According to the statement of unaudited consolidated financial results, revenue from operations for the quarter ended 30.09.2026 was Rs 4,388.90 cr, up from Rs 4,295.50 cr in the corresponding quarter ended 30.09.2025. Total income, including other income, was Rs 4,423.40 cr versus Rs 4,388.50 cr a year earlier.
Total expenses for the quarter were Rs 4,361.90 cr compared with Rs 4,205.30 cr in the same quarter last year. Within this, cost of materials consumed increased to Rs 1,669.00 cr from Rs 1,367.50 cr, and purchases of stock-in-trade rose to Rs 311.20 cr from Rs 135.00 cr. Depreciation and amortisation expense also increased to Rs 563.80 cr from Rs 473.00 cr, while finance costs were Rs 240.10 cr versus Rs 272.20 cr. Employee benefits expense was Rs 891.90 cr, broadly similar to Rs 898.20 cr a year earlier, and other expenses were Rs 1,189.20 cr compared with Rs 1,028.10 cr.
Profit before exceptional items and tax (labelled as profit before share of profit of joint venture and associate, exceptional items and tax) was Rs 61.50 cr, down from Rs 183.20 cr in the corresponding prior quarter. After an exceptional loss of Rs (6.70) cr, profit before tax stood at Rs 54.80 cr versus Rs 171.30 cr a year ago.
Tax expense for the quarter comprised a current tax charge of Rs 30.80 cr and a deferred tax credit of Rs (32.70) cr, compared with a current tax charge of Rs 59.30 cr and a deferred tax credit of Rs (20.80) cr in the year-ago quarter. Profit for the period was Rs 56.70 cr, compared with Rs 132.80 cr in the quarter ended 30.09.2025. Basic earnings per share (face value Rs. 5) for the quarter were 0.25, versus 0.66 in the corresponding prior period, as per the statement of financial results.
Get Biocon Ltd's next results the minute they're filed
Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.
- We'll start you off following BIOCON.
- 14 days free, no card. After that you keep a free account.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.